• Nutritional Sciences
• /
• v.9 no.3
• /
• pp.152-158
• /
• 2006

Helicobacter pylori (H. pylori) infection rapidly stimulated either COX-2 or 5-LOX and released arachidonic acid metabolites that have been considered as pivotal mediators in H. pylori-induced inflammatory responses. To determine whether red ginseng extract (RGE) can suppress the biosynthesis of 5(S)-hydroxyeicosatetraenoic acids (HETE), a precursor metabolite of leukotrienes B4 (LTB4) in H. pylori-provoked inflammatory responses in gastric epithelial cells, the biosynthesis of monohydroxy fatty acids was measured using radioactive arachidonic acid and validated by RP-HPLC using non-radioactive AA as substrate in AGS cells cocultured with H. pylori (ATCC 43504) with or without pretreatment of RGE. Among three known major HETEs, H. pylori infection specifically induced the biosynthesis of $^{14}C-5(S)-HETE$ rather than the complex of $^{14}C-15S-/^{14}C-12(S)-HETE$ from $^{14}C-AA$, concomitantly obtained by HPLC(p<0.01). RGE, 1 to $100{\mu}g/ml$, selectively suppressed H. pylori-stimulated $^{14}C-5(S)-HETE$ production implying the attenuation of 5-lipoxygenase activity, of which was similar to known LOX inhibitor NDGA $(10{\mu}M)$ (p<0.01). However, the amount of 5(S)-HETE was significantly reduced by higher dose of RGE $(100{\mu}g/ml)$ (p<0.05). These results indicated that LOX pathway might be one of principle pathogenic mechanisms of H. pylori and red ginseng could be a nutraceutical against H. pylori infection through inhibiting action of LOX activity.

• Korean Journal of Food Science and Technology
• /
• v.29 no.2
• /
• pp.355-361
• /
• 1997

This study was carried out to investigate the acute cutaneous enzymatic antioxidant activity of green tea extracts (GTE) on hairless mice skin after a signal exposure to ultraviolet B radiation. GTE has been in corporated at concentration of 5, 25, 50 and $100\;{\mu}g$ into hairless mice skin. Under exposure conditions of $1.0\;joule/cm^{2}$, impairment of cutaneous enzymatic activity was observed. Catalase and glutathione reductase were significantly influenced in dose-dependent manner by GTE, however glutathione peroxidase and superoxide dismutase were not affected. To measure inhibition effect of the GTE on lipoxygenase. $50\;{\mu}g$ GTE extract was added in vitro to arachidonis acid. GTE showed higher inhibition effect on 5-hydroxyeicosatetraenoic acid (HETE) and 8-HETE than metalolic products of 12- or 15-HETE. The addition of 5, 25, 50 and $100\;{\mu}g$ GTE inhibited the metabolite formation of 5-HETE by 32, 52, 62 and 80%, respectively, and the metabolite formation of 8-HETE by 36, 47, 70 and 84%, respectively.

• Archives of Pharmacal Research
• /
• v.25 no.6
• /
• pp.747-758
• /
• 2002

The skin displays a highly active metabolism of polyunsaturated fatty acids (PUFA). Dietary deficiency of linoleic acid (LA), an 18-carbon (n-6) PUFA, results in characteristic scaly skin disorder and excessive epidermal water loss. Although arachidonic acid (AA), a 20-carbon (n6) PUFA, is metabolized via cyclooxygenase pathway into predominantly prostaglandin $E_2(PGE_2)$ and $PGF_{2{\alpha}}$, the metabolism of AA via the 15-lipoxygenase (15-LOX) pathway, which is very active in skin epidermis and catalyzes the transformation of M into predominantly 15S-hydroxyeicosatetraenoic acid (15S-HETE). Additionally, the 15-LOX also metabolizes the 18-carbon LA into 13S-hydroxyoctadecadienoic acid (13S-HODE), respectively. Interestingly, 15-LOX catalyzes the transformation of $dihomo-{\gamma}-linolenic$ acid (DGLA), derived from dietary gamma-linolenic acid, to 15S-hydroxyeicosatrienoic acid (15S-HETrE). These monohydroxy fatty acids are incorporated into the membrane inositol phospholipids which undergo hydrolytic cleavage to yield substituted-diacylglycerols such as 13S-HODE-DAG from 13S-HODE and 15S-HETrE-DAG from 15S-HETrE. These substituted-monohydroxy fatty acids seemingly exert anti-inflammatory/antiproliferative effects via the modulation of selective protein kinase C as well as on the upstream/down-stream nuclear MAP-kinase/AP-1/apoptotic signaling events.